Life Sciences Information Technology (IT) Market Outlook Signals Expansion To $56.16 Billion Through 2030

The life sciences information technology (IT) sector is on the brink of significant expansion, driven by technological advancements and increasing demand for efficient data solutions. As the industry evolves, it is set to witness substantial growth fueled by innovative tools and integration platforms that cater specifically to the unique needs of life sciences research and development.

Forecasted Expansion and Market Size of the Life Sciences IT Market
The life sciences information technology market is projected to grow rapidly, reaching a valuation of $56.16 billion by 2030. This growth reflects a robust compound annual growth rate (CAGR) of 14.0%. Key contributors to this upward trend include escalating investments in cloud-native life sciences IT, increased utilization of AI-powered bioinformatics, wider implementation of interoperable healthcare data systems, and a rising demand for tools that enable real-time collaboration in research. Additionally, the sector is experiencing a heightened emphasis on cybersecurity measures tailored to life sciences, ensuring data protection and compliance.

The life sciences information technology (it) market size has grown rapidly in recent years. It will grow from $29.14 billion in 2025 to $33.3 billion in 2026 at a compound annual growth rate (CAGR) of 14.3%. The growth in the historic period can be attributed to expansion of digital data generation in life sciences, increasing complexity of clinical trial management, adoption of electronic laboratory systems, growth of bioinformatics research, rising regulatory data requirements.

Download a free sample of the life sciences information technology (it) market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19547&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Driving Factors Behind Growth in the Life Sciences IT Market
One significant growth driver is the surge in investment toward cloud-native life sciences IT platforms. These cloud-based solutions offer scalability and flexibility, which are essential for handling vast, complex datasets common in life sciences research.
Moreover, the widespread adoption of AI-driven bioinformatics tools is revolutionizing data analysis and interpretation processes. By enabling faster and more accurate insights, these technologies are accelerating drug discovery and clinical research efforts globally.

Leading Companies Influencing the Life Sciences Information Technology Landscape
Key players shaping this market include renowned firms such as Veeva Systems Inc., Medidata Solutions Inc., Oracle Corporation, SAP SE, International Business Machines Corporation, and Microsoft Corporation. Other influential companies involved are accenture* plc, Cognizant Technology Solutions Corporation, Dassault Systèmes SE, SAS Institute Inc., PTC Inc., Infor Inc., LabWare Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Certara Inc., IQVIA Holdings Inc., ArisGlobal LLC, Dotmatics Limited, and Benchling Inc.

View the full life sciences information technology (it) market report:
https://www.thebusinessresearchcompany.com/report/life-sciences-information-technology-it-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Notable Partnership Advancing Life Sciences IT Solutions
In a recent development from January 2024, DNAnexus Inc., a US-based provider of precision health data cloud services, teamed up with Poland's Intelliseq. This collaboration integrates clinical reporting and automated genomic variance interpretation into DNAnexus's Precision Health Data Cloud. The partnership aims to streamline next-generation sequencing data analysis and improve insights into somatic cancers and hereditary conditions. DNAnexus customers will now have direct access to Intelliseq's tertiary analysis tools within this cloud environment, enhancing research efficiency and depth.

Technological Innovations Shaping the Life Sciences IT Market
Market leaders are increasingly focused on creating advanced cloud-native SaaS platforms, designed to be scalable, cost-effective, and compliant with industry regulations. These platforms enhance collaboration and data integration, speeding up innovation in life sciences.
For example, in June 2023, Revvity Inc., a biotechnology firm from the US, launched the Signals Research Suite-a cloud-native SaaS platform aimed at improving scientific collaboration in drug discovery and specialty chemical development. This suite comprises applications like Signals Notebook, VitroVivo, and Inventa, supporting all phases of drug development from early research to safety testing. Its standout features include integrated analytics powered by TIBCO Spotfire, seamless ChemDraw integration, and a customizable user interface. Additionally, it offers secure single sign-on, centralized data access, and regular updates, enabling researchers to focus fully on experiments without switching between multiple software.

Segment Analysis Highlighting the Core of Life Sciences IT Market Growth
This market is categorized primarily by type, solution, and end-user segments.
1) Types include Software and Services.
2) Solutions cover Drug Discovery Informatics, Clinical Trial Management, Bioinformatics, Laboratory Information Management, and others.
3) End users consist of Pharmaceutical and Biotechnology companies, Contract Research and Development Organizations (CROs), and various other users.

Further subcategories detail software offerings such as Laboratory Information Management Systems (LIMS), Electronic Lab Notebooks (ELN), Clinical Trial Management Systems (CTMS), Regulatory Compliance Software, Bioinformatics Software, Data Analytics and Visualization Tools, and Pharmaceutical Manufacturing Software.
Service segments incorporate Implementation and Integration, Consulting, Training and Education, Managed IT, Support and Maintenance, Data Management, Outsourcing, Validation, and Cloud Computing Services.

Together, these segments underscore the multifaceted nature of the market, reflecting its broad application and critical role in advancing life sciences research and healthcare innovation through IT solutions.

New additions to our 2026 reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.